20 Jan 2018,
  • HSI:
    32,254.89 132.95 (0.41%)
    13,179.52 84.60 (0.65%)
    42,169.74 118.02 (0.28%)
    260.91 0.20 (0.08%)
  • HSCEI:
    13,179.52 84.60 (0.65%)
    4,745.79 38.56 (0.82%)
    11,631.17 71.26 (0.62%)
    21,275.04 129.50 (0.61%)
  • Hang Seng Index
  • 32,254.89

  • 132.95 (0.41%)
HSCI 13,179.5 84.6
HKSPLC25 42,169.7 118.0
HKSPGEM 260.9 0.2
HSCEI 13,179.5 84.6
HSCCI 4,745.8 38.6
HSFML25 11,631.2 71.3
H-FIN 21,275.0 129.5
Stay Connected With EQS TodayIR

Bloomage Bio Technology Corporation Limited (00963.HK)

+ More Announcements




2017 (IR)
2016 (AR)
2016 (IR)


  • 2016 Annual R ...
  • 2016 Interim ...
  • 2015 Annual R ...
Bloomage BioTechnology Corporation Limited (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963...
+ More Company Profile

Ms. Zhao Yan - Chairman and Executive Director

Ms. Zhao Yan, aged 46, is the Chairman and an executive Director. Ms. Zhao had been a director of Bloomage Biopharm since 2003. Except for Bloomage Freda USA, she is a director of all the subsidiaries of the Company. Ms. Zhao graduated with a bachelor's degree in science with major in biology from the East China Normal University (華東師範大學) in 1986 and completed an international MBA program organized by the China Center for Economic Research at Peking University from 2000 to 2002, and was awarded a master degree of business administration by Fordham University of the US in 2002. From 2000 to 2002, she was the general manager of Bloomage Holystar Investment Co., Ltd. (華熙昕宇投資有限公司), a company engaged in the provision of venture capital, investment management and consultancy services and business management consultancy services. Presently, Ms. Zhao is also the chairman of Bloomage International Investments Group Inc. (formerly known as Bloomage Investments Co., Ltd) ("Bloomage International"), an investment holding company (the subsidiaries of which are principally engaged in property development and investments in the PRC as well as operation and management of stadium and commercial projects in the PRC). Ms. Zhao is primarily responsible for the Group's corporate policy formulation, business strategic planning and business development. Ms. Zhao is the sole director and shareholder of AIM First Investments Limited which hold 58.5% Shares in the Company.

Mr. Jin Xuekun - Executive Director and the Chief Executive Officer

Mr. Jin Xuekun, aged 48, is the Executive Director and the Chief Executive Officer ,graduated from Fordham University with a Master’s degree of Business Administration in 2002. Mr. Jin has over 20 years’ experience in the sale and marketing of medical instruments and he was able to bring remarkable improvements to the performance and results of the companies he worked at during his service in these companies. He worked at China Rehabilitation Research Center from 1987 to 1993 and was responsible for medical imaging. From 1994 to 2001, he worked at Sanko Medical Ltd. and was responsible for PRC market. He worked at Chindex (Beijing) International Trade Company Limited from 2001 to 2006 as vice president and was responsible for the marketing of medical imaging equipment in the PRC. During that period, Mr. Jin adopted the direct mixed marketing model and brought innovation in respect of strategy formation, establishment of brand and teamculture and marketing strategy to that company. Since 2006, Mr. Jin has been the general manager of Esaote (Shenzhen) Medical Equipment Co. Ltd. and has been responsible for the operation in the PRC in respect of the manufacturing, research and development of equipment. While serving as the general manager of Esaote (Shenzhen) Medical Equipment Co. Ltd., Mr. Jin has put emphasis on the management of corporate strategy, innovation of business model, establishment of corporate culture and reform in areas such as efficiency of structure, optimization of process, integration of resources and incentive systems. Mr. Jin had been an independent non-executive Director from 18 June 2012 to 29 October 2013.

Mr. Gong Anmin - Executive Director

Mr. Gong Anmin, aged 50, joined the Group as the chief financial officer of the Company in January 2014. Mr. Gong is also the general manager of Bloomage Freda Biopharmaceutical Co., Ltd. and Shandong Bloomage Hyinc Biopharm Company Limited. Mr. Gong graduated with a bachelor’s degree in economics from the Central University of Finance and Economics in the People’s Republic of China in 1988 and completed an international MBA program organized by the China Center for Economic Research at Peking University from 2000 to 2002, and was awarded a master degree of business administration by Fordham University in the US in 2002. He had worked in several large state-owned enterprises and foreign enterprises for years, and thus had extensive experience in financial management and corporate governance.

Ms. Wang Aihua - Executive Director

Ms. Wang Aihua, aged 34, was appointed as an executive Director on 15 September 2011. She graduated from Yanshan University (燕山大學) (formerly known as The Northeast Heavy Machinery Institute (東北重型機械學院)) in 1999 with a bachelor's degree in science major in international economic and trading. She further obtained a master of business administration degree from Yanshan University in 2004 with a major in the management science and engineering from 2001 to 2004. Ms. Wang worked as an analyst for Golden Credit Rating International Co., Ltd. from 2004 to 2007 and was responsible for analysis and assessment of company solvency and major loan projects. She had also been the secretary to the Chairman and the Manager of the overseas business department of Bloomage International since July 2007 up to September 2011. She is responsible for strategic development and capital management of the Group. Ms. Wang is a director of Bloomage Biopharm, Beijing Bloomage Hyinc and Shandong Bloomage Hyinc. She joined the Group in December 2008.

Mr. Yau Wai Yan - Non-executive Director

Mr. Yau Wai Yan, aged 40, is the financial controller and company secretary of the Company. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants. Mr. Yau graduated from the Hong Kong University of Science and Technology with a bachelor‘s degree in professional accounting. Prior to joining the Company, Mr. Yau had worked for an international accounting firm for over 10 years, and has extensive experience in finance and accounting. Mr. Yau is a director of a subsidiary of the Company.

Ms. Zhan Lili - Independent Non-executive Director

Ms. Zhan Lili, aged 40, was appointed as an independent non-executive Director on 1 September 2008. She completed her studies in business administration at the Faculty of Business Administration of Capital University of Economics and Business in 2003. Ms. Zhan was an assistant to the General Manager of Tomson (Shanghai) Company Limited (湯臣高爾夫 (上海) 有限公司) from 2000 to 2001, worked in the human resource department of the Beijing branch of Industrial Bank Co., Ltd. (興業銀行) from 2003 to 2007 and has been a president assistant of Beijing Hai Dian Science & Technology Development Co., Ltd. (北京海澱科技發展有限公司), a company engaged in electronics and information technology, environmental protection materials, property development and e-business, since 2007.

Mr. Li Junhong - Independent Non-executive Director

Mr. Li Junhong, aged 47, graduated from Central University of Finance and Economics (中央財經大學) with a Bachelor degree in Accounting in 1989. He studies in the International Executive Master of Business Administration programme at the China Center for Economic Research at Peking University (北京大學中國經濟研究中心) from 2000 to 2002 and obtained a Master of Business Administration from Fordham University in 2002. He is also a member of The Chinese Institute of Certified Public Accountants. From January 2008 to December 2008, Mr. Li had been an executive director of Hong Kong Life Sciences and Technologies Group Ltd. (香港生命科學技術集團有限公司) (formerly known as Zmay Holdings Limited and New Chinese Medicine Holdings Limited) (stock code: 8085), a company listed on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited. He has over 20 years of experience in auditing, accounting, merger and acquisition consultancy and management consultancy with local accountants firms and private companies. He was a partner in Beijing Tianhua CPAs (北京天華會計師事務所). Mr. Li is now the executive vice president and the financial controller of Zhongrong Financial Investment Management Company Limited (中融金匯投資管理有限公司

Mr. Hai Wen - Independent Non-executive Director

Mr. Hai Wen, aged 61, graduated from Peking University with a Bachelor degree in Economics in 1982. He obtained a doctorate degree in Economics from the University of California, Davis in 1991. He is a professor in Economics and doctoral supervisor of Peking University and currently serves as the deputy director of the University Council of Peking University (北京大學校務委員會) and the dean of the HSBC Business School of Peking University (北京大學䁩豐商學院). He had been a permanent deputy director of The China Center for Economic Research at Peking University (北京大學中國經濟研究中心), vice principal of Peking University and the dean of the Shenzhen Graduate School of Peking University (北京大學深圳研究生院). Mr. Hai had compiled and translated more than ten books on Economics and has won several awards in the fields of Economics and education.

+ More Board of Directors


  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      


Listed Date 03 Oct 2008

Address 33/F, Tower D, CITC,
6A Jianguomenwai Avenue,
Chaoyang District, Beijing

Telephone (86 10) 8567 0099

Facsimile (86 10) 6563 0000

Email info@biobloomage.com

No. of Click Rate